Tirzepatide is a dual GLP-1 / GIP receptor agonist studied for blood sugar regulation, insulin secretion and appetite control.
Interested in this product? Reach us via the contact details below.
Tirzepatide works by stimulating both the GLP-1 and GIP receptors, which are involved in regulating blood sugar levels, insulin secretion, and appetite.
As a dual incretin receptor agonist, Tirzepatide activates two complementary pathways at the same time, which is why it is frequently compared with single-target GLP-1 analogues such as Semaglutide in metabolic research.
Supplied as a lyophilised powder in sealed vials. Each batch is produced under GMP-compliant conditions and ships with a batch-specific Certificate of Analysis (HPLC purity).
Disclaimer:
All products on this site are for Research, Development use only. Products are Not for Human use of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
